CDC5L and cancer: Therefore, BTYNB can be used as a reagent to target multiple pathways (C-Myc, CDC5L, EZH2, etc.)or be used in combinatorial targeting strategies to modulate the cell cycle and enhance apoptosis of cancer cells more effectively.